Navigation Links
InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office
Date:10/20/2011

LEXINGTON, Mass., Oct. 20, 2011 /PRNewswire/ -- InaVein, LLC today announced publication of a peer-reviewed paper that examines use of the TRIVEX transilluminated powered phlebectomy (TIPP) System for removal of varicose veins in a clinical office rather than a hospital setting. The paper, Transilluminated Powered Phlebectomy in an Office Setting:  Procedural Considerations and Clinical Outcomes was authored by Gregory A. Spitz, M.D., FACS (AmeriVein Systems, Aurora, Illinois) and published in the October 2011 edition of the Journal of Endovascular Therapy.  The TRIVEX procedure was successfully completed on all patients using only local tumescent anesthesia.  There were no reports of hematomas, deep vein thrombosis, or extended parasthesia at the 3-month follow up.  Patients reported a high level of satisfaction (9.6 out of 10) in this setting. A mean procedure time of 13.5 minutes (+/-3.7 min) was reported.  Thirty-three of the 36 patients underwent concurrent endovenous ablation procedures.  According to Dr. Spitz, "More recent cases have confirmed that when patients are prepared for an in-office procedure and treated by a physician well versed in the TIPP procedure and tumescent anesthesia, the outcomes are mutually satisfying. There should also be an economic benefit, with reduced cost to the healthcare system, as has been realized in other clinical situations."  InaVein CEO Keith Jansen said, "This clinical evidence highlights the benefits of the TRIVEX procedure in an office environment for patients who have varicose veins -- a condition that impacts 25 - 40 million Americans and over 700 million people globally."

About InaVein

InaVein, LLC is a privately held company engaged in the development, manufacture, marketing and commercialization of unique medical devices for the treatment of vein disease. The company's flagship product, The TRIVEX System, is the first technology to provide vein specialists with a minimally invasive technique to remove varicose veins safely and efficiently under direct vision. Since 2003, thousands of patients worldwide have been successfully treated using The TRIVEX System in a surgical setting to completely remove their varicose veins.

For more information please contact:
InaVein, LLC
Keith Jansen
President & CEO
617.245.1965 ext. 1102
Email: kjansen@inavein.com

Website: www.inavein.com


'/>"/>
SOURCE InaVein, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Epilepsy Therapy Project Announces "Shark Tank" Competition to Identify the Most Innovative, New Products for People with Epilepsy
2. China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc.
3. Misonix Announces the Sale of Its Laboratory and Forensic Safety Products Business for $1.5 Million
4. The Society for Minimally Invasive Spine Surgery Announces Agreement With joimax® to Support Creation and Launch of SMISS Registry for Endoscopic Spine Surgery
5. WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System
6. Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call
7. Bend Research Announces New Chief Financial Officer
8. Young Innovations, Inc. Announces Record EPS for the Quarter and Record Sales and EPS for the Nine-Months Ended September 30, 2011 and Declares Quarterly Dividend
9. Amgen Announces Webcast of 2011 Third Quarter Financial Results
10. Pacira Pharmaceuticals, Inc. Announces New Data Demonstrating Longer Time to First Opioid Use and Reduction in Opioid-Related Adverse Events With EXPAREL™ Compared to Bupivacaine HCl
11. Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 2016 Yissum Research Development ... today that it had signed an exclusive world-wide licensing ... of novel protein degradation and immunomodulatory drugs for cancer ... drug candidates representing first-in-class therapy for hematologic and solid ... The novel technology was developed by ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
(Date:5/3/2016)... -- Research and Markets has announced the ... Market Outlook 2020" report to their offering. ... technology has improved significantly in past years due to ... coming years. Many cancer drugs have been developed by ... also expected to be developed with its help. They ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... A local ... that more than 40 percent of participating fifth-grade students already have or are ... and Asthma Clinical Research in the Division of Pulmonary, Allergy and Critical Care ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Dr. Benjamin ... in non-surgical hair loss treatment. Dr. Stong is double board certified and the ... for the treatment of hair loss. Non-surgical therapies such as stem cells can ...
(Date:5/5/2016)... , ... May 05, 2016 , ... The 2016 Nike ... Derek Pittman, along with his university coaching staff. Together they bring their winning Vandals ... sessions run for youth players ages 5-13, and high school players. Session dates are ...
(Date:5/5/2016)... ... May 05, 2016 , ... When stiff and achy ... alleviate the pain that’s a common osteoarthritis (OA) symptom. Yet, numerous clinical studies ... with arthritis. , “Physical therapy exercises are commonly prescribed to individuals with ...
(Date:5/5/2016)... ... May 05, 2016 , ... The Lung Institute will celebrate its three-year ... seminar at most clinic locations throughout the month of May. To date, the Lung Institute ... rapid growth that we’ve seen is a testament to the success of this treatment and ...
Breaking Medicine News(10 mins):